“This case challenges current paradigms, demonstrating that amivantamab monotherapy can effectively target rare EGFR mutations, achieve durable extracranial and CNS disease control, and potentially ...

Stage 4 lung cancer, also called metastatic lung cancer, is the most aggressive and life-threatening stage of the disease. By this point, cancer has spread from the lungs to vital organs such as the ...

An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of ...

Advanced MRI-based mapping in a 2014–2020 stereotactic radiosurgery cohort quantified incidental SVZ and hippocampal dose while targeting metastases in 138 NSCLC patients. Incremental dose to ...

CNS metastases in EGFR-mutant NSCLC are prevalent and worsen prognosis, especially with acquired progression during treatment. Amivantamab plus lazertinib shows promising CNS activity, but current ...

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small ...

As Tania Rodrigues drove to work one morning in January 2024, something unusual happened with her vision. “All of a sudden, I was looking through a kaleidoscope or perhaps like a fly’s eye,” the ...